{"id":"https://openalex.org/W2024254896","doi":"https://doi.org/10.1182/blood-2003-07-2527","title":"A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia","display_name":"A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia","publication_year":2004,"publication_date":"2004-03-15","ids":{"openalex":"https://openalex.org/W2024254896","doi":"https://doi.org/10.1182/blood-2003-07-2527","mag":"2024254896","pmid":"https://pubmed.ncbi.nlm.nih.gov/15010369"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2003-07-2527","doi":"https://doi.org/10.1182/blood-2003-07-2527","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2003-07-2527","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2024254896"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.25405/ncl.34616178","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025823276","display_name":"Elaine Willmore","orcid":"https://orcid.org/0000-0002-4762-094X","observed_orcids":["https://orcid.org/0000-0002-4762-094X"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elaine Willmore","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011803200","display_name":"Sarah de Caux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah de Caux","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078060828","display_name":"Nicola J. Sunter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola J. Sunter","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112102930","display_name":"Michael J. Tilby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael J. Tilby","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081247376","display_name":"Graham Hunter Jackson","orcid":"https://orcid.org/0000-0003-0756-969X","observed_orcids":["https://orcid.org/0000-0003-0756-969X"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham H. Jackson","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022208465","display_name":"Caroline A. Austin","orcid":"https://orcid.org/0000-0002-1921-5947","observed_orcids":["https://orcid.org/0000-0002-1921-5947"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Caroline A. Austin","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113573214","display_name":"Barbara W. Durkacz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Barbara W. Durkacz","raw_affiliation_strings":["From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the School of Cell and Molecular Biosciences, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom; and Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725","https://openalex.org/I84884186"]},{"raw_affiliation_string":"Department of Hematology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, University of Newcastle-upon-Tyne Medical School, Newcastle-upon-Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.4058,"has_fulltext":false,"cited_by_count":279,"citation_normalized_percentile":{"value":0.88931493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"103","issue":"12","first_page":"4659","last_page":"4665"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nu7026","display_name":"NU7026","score":0.996999979019165},{"id":"https://openalex.org/keywords/topoisomerase-ii-poisons","display_name":"topoisomerase II poisons","score":0.9829999804496765},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.703000009059906},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.7760000228881836},{"id":"https://openalex.org/keywords/non-homologous-end-joining","display_name":"non-homologous end joining","score":0.9940000176429749},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.7910000085830688},{"id":"https://openalex.org/keywords/drug-potentiation","display_name":"drug potentiation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/leukemia-treatment","display_name":"leukemia treatment","score":0.41499999165534973},{"id":"https://openalex.org/keywords/idarubicin","display_name":"idarubicin","score":0.7139999866485596},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7509999871253967},{"id":"https://openalex.org/keywords/amsacrine","display_name":"amsacrine","score":0.7279999852180481},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.8119999766349792},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9449999928474426}],"concepts":[{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.8153253793716431},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7842491865158081},{"id":"https://openalex.org/C2780500152","wikidata":"https://www.wikidata.org/wiki/Q2784004","display_name":"Amsacrine","level":4,"score":0.761293888092041},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.6937850713729858},{"id":"https://openalex.org/C2779117419","wikidata":"https://www.wikidata.org/wiki/Q1063862","display_name":"Idarubicin","level":4,"score":0.5730079412460327},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.5291041731834412},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4722660779953003},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4659598469734192},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4496139883995056},{"id":"https://openalex.org/C2777827897","wikidata":"https://www.wikidata.org/wiki/Q5436005","display_name":"Farnesyltransferase inhibitor","level":5,"score":0.44610467553138733},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38253265619277954},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.37312960624694824},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36235618591308594},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3354756236076355},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3029897212982178},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.24035367369651794},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.20743286609649658},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.20712921023368835},{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.12028077244758606},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09537807106971741},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.09408754110336304},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09084904193878174},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07024046778678894},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011838","descriptor_name":"Radiation-Sensitizing Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051747","descriptor_name":"DNA-Activated Protein Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1182/blood-2003-07-2527","doi":"https://doi.org/10.1182/blood-2003-07-2527","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2003-07-2527","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:15010369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15010369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"doi:10.25405/ncl.34616178","doi":"https://doi.org/10.25405/ncl.34616178","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34616178","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34616178.v1","doi":"https://doi.org/10.25405/ncl.34616178.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34616178.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.25405/ncl.34616178","doi":"https://doi.org/10.25405/ncl.34616178","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34616178","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9074000120162964,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W212335784","https://openalex.org/W1509713940","https://openalex.org/W1510237964","https://openalex.org/W1552661588","https://openalex.org/W1600510649","https://openalex.org/W1631113236","https://openalex.org/W1663875691","https://openalex.org/W1969357866","https://openalex.org/W1970732530","https://openalex.org/W1973179542","https://openalex.org/W1975843196","https://openalex.org/W1988862874","https://openalex.org/W1989425995","https://openalex.org/W1992688638","https://openalex.org/W1999161678","https://openalex.org/W2000912535","https://openalex.org/W2003139749","https://openalex.org/W2011522975","https://openalex.org/W2018862418","https://openalex.org/W2024954071","https://openalex.org/W2027054538","https://openalex.org/W2043877228","https://openalex.org/W2054814487","https://openalex.org/W2061527580","https://openalex.org/W2076040064","https://openalex.org/W2076418100","https://openalex.org/W2077757406","https://openalex.org/W2080409413","https://openalex.org/W2084007693","https://openalex.org/W2094455327","https://openalex.org/W2103867015","https://openalex.org/W2107551082","https://openalex.org/W2109881523","https://openalex.org/W2110177038","https://openalex.org/W2122210452","https://openalex.org/W2123374199","https://openalex.org/W2128590787","https://openalex.org/W2130728712","https://openalex.org/W2130737261","https://openalex.org/W2130883309","https://openalex.org/W2130952513","https://openalex.org/W2144074508","https://openalex.org/W2173552767","https://openalex.org/W2297718137","https://openalex.org/W2341695868","https://openalex.org/W2398240122","https://openalex.org/W2414304097","https://openalex.org/W2418411336"],"related_works":["https://openalex.org/W4248427488","https://openalex.org/W7208584512","https://openalex.org/W2987726691","https://openalex.org/W2130266193","https://openalex.org/W4385461169","https://openalex.org/W3082021722","https://openalex.org/W2042677990","https://openalex.org/W2004285724","https://openalex.org/W7203950127","https://openalex.org/W2099391093"],"abstract_inverted_index":{"We":[0,68],"report":[1],"for":[2,32,117,122],"the":[3,6,70,80,94,147],"first":[4],"time":[5],"use":[7],"of":[8,13,56,72,97,125,149,188,191,197],"a":[9,29,73,200],"selective":[10],"small-molecule":[11],"inhibitor":[12],"DNA":[14,45],"repair":[15,59],"to":[16,44,64,82,119],"potentiate":[17,137],"topoisomerase":[18],"II":[19,36,66,84,193],"(topo":[20],"II)":[21],"poisons,":[22],"identifying":[23],"DNA-dependent":[24],"protein":[25],"kinase":[26],"(DNA-PK)":[27],"as":[28],"potential":[30],"target":[31],"leukemia":[33,88],"therapy.":[34],"Topo":[35],"poisons":[37,85,194],"form":[38],"cleavable":[39,155],"complexes":[40],"that":[41],"are":[42],"processed":[43],"double-strand":[46],"breaks":[47],"(DSBs).":[48],"DNA-PK":[49,75],"mediates":[50],"nonhomologous":[51],"end":[52],"joining":[53],"(NHEJ).":[54],"Inhibition":[55],"this":[57],"DSB":[58,180],"pathway":[60],"may":[61],"sensitize":[62],"cells":[63],"topo":[65,83,151,192],"poisons.":[67],"investigated":[69],"effects":[71],"novel":[74],"inhibitor,":[76],"NU7026":[77,90,134,143,157,189],"(2-(morpholin-4-yl)-benzo[h]chomen-4-one),":[78],"on":[79,162],"response":[81],"using":[86],"K562":[87],"cells.":[89],"(10":[91],"microM)":[92],"potentiated":[93],"growth":[95,111],"inhibition":[96,112,196],"idarubicin,":[98],"daunorubicin,":[99],"doxorubicin,":[100],"etoposide,":[101],"amsacrine":[102],"(mAMSA),":[103],"and":[104,199],"mitroxantrone":[105],"with":[106],"potentiation":[107,190],"factors":[108],"at":[109],"50%":[110],"ranging":[113],"from":[114],"approximately":[115,120],"19":[116],"mAMSA":[118],"2":[121],"idarubicin":[123],"(potentiation":[124],"etoposide":[126],"was":[127,171,182],"confirmed":[128],"by":[129,173,184],"clonogenic":[130],"assay).":[131],"In":[132],"contrast,":[133],"did":[135,144],"not":[136,145],"camptothecin":[138],"or":[139,153],"cytosine":[140],"arabinoside":[141],"(araC).":[142],"affect":[146],"levels":[148,181],"etoposide-induced":[150,167,179],"IIalpha":[152],"beta":[154],"complexes.":[156],"alone":[158],"had":[159],"no":[160],"effect":[161],"cell":[163],"cycle":[164],"distribution,":[165],"but":[166],"accumulation":[168],"in":[169,178],"G2/M":[170,201],"increased":[172,183],"NU7026.":[174,185],"A":[175],"concentration-dependent":[176],"increase":[177],"The":[186],"mechanism":[187],"involves":[195],"NHEJ":[198],"checkpoint":[202],"arrest.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":27}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}